Peter Werth

Part of Softbox Holdings SARL, Softbox (Topco) Ltd. is a British company that provides world-class logistics support. The company was founded in 2014 and is based in Aylesbury, UK. Working with integrators, specialist couriers, and freight forwarding networks, Softbox's cold chain logistics experience has been a key consideration in their drive to create a complete range of high-performance temperature control packaging products for air, sea, and land. Softbox's innovative range of packaging systems, including the CSafe, has enabled them to become the first choice strategic packaging vendor to the pharmaceutical industry. The company's Softbox passive temperature control packaging solutions are trusted by leading pharmaceutical companies and specialist logistics providers.

Guggenheim Strategy Funds Trust is an open-end management investment company. The trust comprises of 3 funds: Guggenheim Strategy Fund I, Guggenheim Strategy Fund II and Guggenheim Strategy Fund III, which invests in a diversified portfolio of debt securities and financial instruments. Guggenheim Strategy Funds Trust was founded on November 8, 2013 and is headquartered in Rockville, MD.

Guggenheim Floating Rate & Income Fund is a newly-organized, diversified, closed-end management investment company. The Fund's objective is to provide a high level of current income while maximizing total return. It invests at least 80% of its assets in floating rate senior secured syndicated bank loans, floating rate revolving credit facilities and floating rate unsecured loans. The company offers opportunities for investors seeking an alternative to traditional fixed-income securities that may help hedge interest rate and inflation exposure. Guggenheim Floating Rate & Income Fund was founded on October 24, 2013 and is headquartered in Lisle, IL.

Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN.

Solaris Pharma Corp. engages in the development and commercialization of specialty pharmaceutical products. Its topical dosage forms that are developed at its facility include ointments, gels, creams, lotions, solutions, sprays, and foams. The company was founded by Lakshmi Raghavan in 2014 and is headquartered in Bridgewater, NJ.

Azalea TopCo, Inc. provides healthcare services. The company was founded in 2016 and is headquartered in New York, NY.

SiO2 Medical Products, Inc. manufactures pharmaceutical products. It offers vials, syringes, cartridges, microplates, blood tubes, and bioscience consumables. The company was founded by Robert Abrams in November 2011 and is headquartered in Auburn, AL.

Softbox Systems Ltd. provides temperature controlled packaging solutions for the biotechnology and pharmaceutical industries. It offers temperature control packaging design, temperature control shipper qualification, temperature control payload optimization and temperature control packaging training. The company was founded in 1995 and is headquartered in Long Crendon, the United Kingdom.

Great Point Partners LLC (Great Point) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Greenwich, Connecticut. The firm was founded in 2003 by Dr. Jeffrey Jay and David Kroin. Great Point provides discretionary investment management services to pooled investment vehicles, which includes hedge funds and private equity funds, as well as separately managed accounts.

Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK.

Part of Merck KGaA, Durachemie GmbH is a German company that specializes in medicinal chemicals and botanical products. The company is based in Wolfratshausen, Germany. Durachemie was acquired by Merck KGaA from Wyeth LLC on October 01, 1997.

The American Hospital Association owns and operates hospitals. Its services include patient care, conducting research and development projects on the structuring and delivery of health care services, and providing educational programs and opportunities. The company was founded in September 1899 and is headquartered in Chicago, IL.

Guggenheim Energy & Income Fund is a closed-end investment fund. It is a non-diversified, non-traded management investment company. Its objectives are to provide high income and seek capital appreciation. The company was founded on April 28, 2015 and is headquartered in Chicago, IL.

Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ.

The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012.

MedRhythms, Inc. is a digital therapeutics company based in Portland, ME. The company uses sensors, music, and software to develop evidence-based neurologic interventions to measure and improve walking. MedRhythms is dedicated to developing direct-stimulation digital therapeutics that provide direct stimulation to enable the mechanism of action in each relevant population. The company has an active pipeline of prescription digital therapeutics targeting rehabilitation and prevention in areas of neurologic injury and disease. The company's platform combines sensors, software, and music with advanced neuroscience to target neural circuitry. MedRhythms is on a mission to help people living with neurologic injuries and diseases optimize their health and independence through next-generation therapeutics to improve brain health. MedRhythms was founded in 2013 by Brian Harris and Owen McCarth, with Brian Harris serving as the CEO since then.

Nuance Designs of CT LLC is a private company that specializes in designing and developing auto-injectors and self-injection devices. The company is based in Woodbridge, CT.

VM Pharma LLC develops and identifies allosteric kinase inhibitors. The firm specializes in the treatment of pain, cancer, and other human diseases. The company is headquartered in Fremont, CA.

Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS.

Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS.

Alzeca Biosciences, Inc. is a company based in Houston, TX. Alzeca is developing a proprietary intravenous contrast agent that targets Alzheimer's disease pathology. The company's targeted agent has shown the ability to detect early stage disease pathology with exceptional resolution and sensitivity using commonly available imaging techniques. The development of the agent was initiated through a collaboration between Dr. Ananth Annapragada and Dr. Jason Eriksen. The company was founded in 2012 by Jason Eriksen, Robin Mansukhani, Ananth Annapragada. The CEO is Carlo Giovanni Medici.